chitosan has been researched along with didanosine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaud, MV; da Silva, CF; Martins, F; Santana, MH; Severino, P | 1 |
| Al-Ghananeem, AM; Florence, R; Malkawi, AH; Saeed, H; Yokel, RA | 1 |
| Ferreira da Silva, C; Martins, F; Santana, MH; Severino, P; Souto, EB | 1 |
3 other study(ies) available for chitosan and didanosine
| Article | Year |
|---|---|
The intestinal permeation of didanosine from granules containing microspheres using the everted gut sac model.
Topics: Animals; Anti-HIV Agents; Chitosan; Didanosine; Duodenum; Intestinal Absorption; Male; Microspheres; Rats | 2009 |
Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by AIDS viruses.
Topics: Administration, Intranasal; Animals; Brain; Chitosan; Chromatography, Liquid; Didanosine; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; HIV Infections; Male; Mass Spectrometry; Microscopy, Electron, Transmission; Nanoparticles; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors | 2010 |
Didanosine-loaded chitosan microspheres optimized by surface-response methodology: a modified "Maximum Likelihood Classification" approach formulation for reverse transcriptase inhibitors.
Topics: Chitosan; Didanosine; Dosage Forms; Microspheres; Reverse Transcriptase Inhibitors; Surface Properties; Technology, Pharmaceutical | 2015 |